Teikyo University Institute of Medical Mycology, 359 Otsuka, Hachioji, Tokyo, 192-0395, Japan.
Mycopathologia. 2022 Dec;187(5-6):491-496. doi: 10.1007/s11046-022-00661-6. Epub 2022 Sep 3.
Luliconazole, recently launched in Japan, is a novel topical imidazole antifungal agent for the treatment of onychomycosis. Using in vitro onychomycosis model, the effect of luliconazole on the morphology of the growing hyphae of Trichophyton mentagrophytes was investigated by scanning electron microscopy (SEM). The model was produced by placing human nail pieces on an agar medium seeded with conidia of T. mentagrophytes. After incubating the agar medium for 3 days, luliconazole was applied to the surface of the nail in which hyphal growth was recognized, then cultured for up to 24 h. The initial change after treatment with the drug was the formation of fine wrinkles on the surface of the hyphae, eventually, the hyphae were flattened, and after that, no hyphal growth was observed. On the other hand, when the nails were pretreated with luliconazole for 1 h, no hyphal growth was observed even after culturing for 24 h. This study suggests that luliconazole has a strong antifungal activity by inhibiting the ability of fungi to grow and the drug has both excellent nail permeation and retention properties.
卢立康唑于近期在日本上市,是一种新型的局部咪唑类抗真菌药物,用于治疗甲真菌病。本研究采用体外甲真菌病模型,通过扫描电子显微镜(SEM)观察卢立康唑对须癣毛癣菌生长菌丝形态的影响。该模型是通过将人指甲片置于接种有须癣毛癣菌分生孢子的琼脂培养基上而产生的。在琼脂培养基中孵育 3 天后,将卢立康唑涂抹于已识别出菌丝生长的指甲表面,然后培养长达 24 小时。用药后的初始变化是菌丝表面形成细小的皱纹,最终菌丝被压平,之后则观察不到菌丝生长。另一方面,当指甲预先用卢立康唑处理 1 小时后,即使培养 24 小时也观察不到菌丝生长。本研究表明,卢立康唑通过抑制真菌的生长能力具有很强的抗真菌活性,并且该药物具有优异的指甲渗透和保持特性。